T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis

Objective : to evaluate changes in T- and B-lymphocyte subpopulations at different stages of rheumatoid arthritis (RA). Patients and methods . The study included 53 patients with a definite RA diagnosis according to the 2010 ACR/EULAR criteria (mean age 54.2 [47; 62] years). Group 1 included 27 pati...

Full description

Saved in:
Bibliographic Details
Published inSovremennai͡a︡ revmatologii͡a Vol. 15; no. 2; pp. 17 - 22
Main Authors Martynova, A. V., Popkova, T. V., Aleksankin, A. P., Gridneva, G. I., Gerasimova, E. V., Gorbunova, Yu. N., Semashko, A. S., Lila, A. M.
Format Journal Article
LanguageEnglish
Russian
Published IMA-PRESS LLC 23.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective : to evaluate changes in T- and B-lymphocyte subpopulations at different stages of rheumatoid arthritis (RA). Patients and methods . The study included 53 patients with a definite RA diagnosis according to the 2010 ACR/EULAR criteria (mean age 54.2 [47; 62] years). Group 1 included 27 patients (25 women and 2 men) without history of synthetic disease modifying anti-rheumatic drugs (sDMARDs) intake, group 2 included 26 patients (22 women and 4 men) receiving sDMARDs (methotrexate or leflunomide). The control group consisted of 29 healthy volunteers (23 women and 6 men), the median age was 58.5 [53; 62] years. In all participants flow cytofluorometry according to the standard technique with immunophenotyping of T- and B-lymphocytes was performed. Results and discussion . Compared to controls, patients in group 1 who had not previously received sDMARDs showed a transient increase in "switched" memory B-cells, transient B-cells, and plasmablasts, which was not observed in patients of group 2 (on sDMARDs therapy). Patients with advanced RA showed a statistically significant decrease in the absolute and relative number of memory B-cells, the absolute and relative number of "switched" B-lymphocytes, as well as the number of plasmablasts and transient cells. In RA patients, a statistically significant rela tionship was established between the number of swollen joints and the level of plasmablasts (r=0.51), memory cells (r=0.54), and "switched" B-cells (r=0.41), p< 0,05 in all cases. There were no statistically significant changes in other subpopulations of B-lymphocytes and the profile of T-lymphocytes. Conclusion . Changes in the B-lymphocyte profile are characteristic of different stages of RA. At an early stage, there is an increase in the number of transient B-lymphocytes, plasmablasts and plasmocytes, and in the advanced stage, a decrease in the level of certain populations of B-lymphocytes, such as memory B-cells and "switched" B-lymphocytes. It can be assumed that the ineffectiveness of sDMARDs is associated with a change in the population composition of B-lymphocytes, which requires further study.
ISSN:1996-7012
2310-158X
DOI:10.14412/1996-7012-2021-2-17-22